Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Allied BiotechROCO:1780 -1.76%77 Days Payable is 18.04 as of Dec. 2025, which is 21% below its 10-year median of 22.92. GuruFocus rates ROCO:1780 with a GF Score™ of 77/100 and a GF Value™ of NT$20.77 (Fairly Valued). The stock has 5 warning signs investors should review. Among 926 Drug Manufacturers companies, Allied Biotech ranks worse than 96.76% on this metric.
The historical rank and industry rank for Allied Biotech's Days Payable or its related term are showing as below:
ROCO:1780'
s Days Payable Range Over the Past 10 Years
Min: 15.34 Med: 22.92 Max: 28.85
Current: 17.77
During the past 13 years, Allied Biotech's highest Days Payable was 28.85. The lowest was 15.34. And the median was 22.92.
ROCO:1780's Days Payable is ranked worse than 96.76% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.455
vs ROCO:1780: 17.77
Allied Biotech's Days Payable
increased
from Dec. 2024 (17.87) to Dec. 2025 (18.04).
It may suggest that Allied Biotechdelayed paying its suppliers.
Allied Biotech Days Payable Related Terms
Allied Biotech Days Payable Historical Data
* Premium members only.
The historical data trend for Allied Biotech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allied Biotech Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Days Payable distribution charts can be found below:
* The bar in red indicates where Allied Biotech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Allied Biotech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allied Biotech (ROCO:1780) has a Days Payable of 18.04 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Allied Biotech and its competitors. This is 21% below median its historical median of 22.92. Over the past decade, Allied Biotech's Days Payable has ranged from 15.34 to 28.85. According to the industry distribution chart, Allied Biotech ranks #896 out of 926 companies in the Drug Manufacturers industry, placing it in the top 96.8%.
Is Allied Biotech's Days Payable too high?
Allied Biotech's current Days Payable of 18.04 is 21% below median its 10-year median of 22.92. Over the past 10 years, this metric has ranged from a low of 15.34 to a high of 28.85. The Drug Manufacturers industry median Days Payable is 90.46. Allied Biotech's value of 18.04 is 80.1% below this industry median. Based on the distribution chart, Allied Biotech ranks #896 out of 926 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Allied Biotech has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Allied Biotech ranks #896 out of 926 companies for Days Payable. This places Allied Biotech in the lower half of its industry. The industry median Days Payable is 90.46. Allied Biotech's value of 18.04 is 80.1% below this benchmark. Historically, Allied Biotech's own Days Payable has ranged from 15.34 to 28.85 over the past decade. While the company's 10-year median is 22.92 vs. the industry median of 90.46, Allied Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.46, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allied Biotech's current Days Payable of 18.04 is 80.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Allied Biotech and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allied Biotech's current Days Payable is 18.04, which is 21% below median its own 10-year median of 22.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.77, compared to a current price of NT$22.30 — trading 7.4% above its estimated fair value. The current Days Payable is 18.04, which is 21% below median its 10-year median of 22.92 and 80.1% below the Drug Manufacturers industry median of 90.46. Allied Biotech's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current Days Payable is 18.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allied Biotech (ROCO:1780) Overvalued in 2026?
Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued.
The current stock price of NT$22.30 is trading 7.4% above its estimated GF Value™ of NT$20.77.
GuruFocus considers Allied Biotech to be Fairly Valued.
Key valuation signals for ROCO:1780:
Days Payable: 18.04 (21% below median its 10-year median of 22.92)
GF Value™: NT$20.77 vs. price of NT$22.30 (7.4% above fair value)
Industry Position: 80.1% below the Drug Manufacturers median (#896 of 926)
No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
77GF Score
Get the complete analysis for ROCO:1780
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1780 has been successfully added to your 
